ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia.

Among genes previously shown to be elevated in “high inflammation” ALS patients, there was indeed a significant trend towards higher expression in our myeloid patient group (e.g., CD14 , RXRA , MMP9 ; P = 0.015; Fig. 7 g, h).

also in 9,775 other papers